Overview

Millions of cancer cases are diagnosed yearly. While a cure has yet to be discovered, one of the most promising new treatments is Multi-Targeted Epigenetic Therapy, or MTET. In Making the Case for MTET, world-renowned oncology expert Dr. Mohammad A. Nezami introduces his revolutionary method of treating patients with advanced cancer by using a careful combination of drugs and genomic sequencing. For some patients with stage four cancer, MTET has been a lifesaving intervention. Dr. Nezami presents 300 case studies of patients with advanced cancer that he treated over ten years of longitudinal tracking with MTET. Through meticulously documented data, lab reports, and full-color photographs to detailed genomic information, Dr. Nezami makes a compelling case for furthering MTET research and focusing on patient-centric care.

Full Product Details

9798986347264

Table of Contents

Reviews

"People in the United States and across the world are typically living decades longer than their predecessors. Over the past century, advances in medical treatments have led to better management and cure for many infectious and heart diseases. Infectious disease is no longer the leading cause of death, and heart disease has now become a chronic condition although it still remains the leading cause of death. Cancer is now competing for the top spot as the leading cause of death, just behind heart disease in the United States. Epigenetics is the study of how our environmental and behavioral changes can affect the way our genes work. Unlike genetic changes, epigenetic changes are reversible. Dr. Nazemi brings a wealth of knowledge and research in the field of Epigenetics, providing his perspective and potential alternative approach to cancer treatment. In the world of personalized medicine where we can sequence genes, create targeted drugs, vaccines and therapies, epigenetics will play a bigger and bigger role. I look forward to Dr. Nezami's contribution to our literature in understanding and alternative approaches in treatment of, ""the Emperor of all maladies"", Cancer. Reza Shirazi, MD, FACRO, EE Radiation Oncologist This book solidifies Dr. Nezami as a powerhouse in oncology and in setting the standard for human excellence! After reading his book I can see that Dr. Nezami is beyond brilliant in his ability to synthesize research information together with clinical practice in meaningful ways for the benefit of healing the patient. All doctors would do well to read his book and pay attention to not only his description and synopsis of the research, but equally as important is his understanding of what makes you a real doctor. It certainly isn't just doing what you are told or mandated by those who hold your salary hostage. It is also not just haphazardly thinking outside the box for the sake of being different. It is closely observing the needs of the patient's body, mind, and soul. It is about being honest with oneself and communicating honestly with the patient so that doctor and patient develop a close relationship, allowing the two to efficiently and clearly work toward the same goal with the same expectations. Dr. Nezami is a master at the art of the doctor patient dance. His compassion and empathy, his desire to pull humans toward a future where there is less pain and suffering has driven him to achieve what he has achieved in the advancement of the field of oncology despite the inertia of the status quo in medicine fighting his efforts in so many ways. Dr. Nezami is a true hero of the ages. Dr John Campise- President- Campise wellness consulting Dr. Nezami is a leading cancer scientist of our times. His insights into the origins of cancer and novel approaches to cancer treatment are both revolutionary and provocative. Generations of physicians and scientists will remember his work. Reinhard W. Schulte, MD, MS, DABR"

Author Information

Mohammad A. Nezami, MD, author of Transition from Crime to Care in Oncology: A Critical Review of Current Cancer Research and Its Applications, is a world-renowned authority on integrative oncology and epigenetic sciences and a graduate of the University of Southern California and University of California San Francisco residencies. He serves as the president of Medical Centers of Hope in California. He has contributed to numerous medical publications and has made presentations to such organizations as the American Society of Clinical Oncology (ASCO) and the American Association for Cancer Research (AACR). Dr. Nezami, who currently teaches and consults other physicians and oncologists, is extensively involved in research and pursuing several clinical trials in integrative oncology and epigenetic sciences.

Tab Content 6

Customer Reviews

Recent Reviews

Countries Available